The appeal of AstraZeneca in Case C-457/10 P has been unsuccessful, but many questions related to this case still remain to be answered by the future jurisprudence. I have started a project, to begin with divided in three sections:
1- definition of relevant product market
2- abuse no 1- marketing authorization
3- abuse no 2- prolongation of the patent protection.
https://www.researchgate.net/project/AstraZeneca_Antitrust_Case-6_12_12/
I invite every one who fits in the category competition lawyer geeks to open discussions, ask questions and bring in new perspectives on this case.
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:62010CJ0457:EN:HTML